Related references
Note: Only part of the references are listed.Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo
T. Kanke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Guide to receptors and channels (GRAC), 3rd edition
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFκB serine 536 phosphorylation in human keratinocytes
Fui Goon Goh et al.
CELLULAR SIGNALLING (2008)
Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells
E. Ritchie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
Jillian G. Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Differential effects of β-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2
P. Kumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The therapeutic potential of proteinase-activated receptors in arthritis
Kathryn A. McIntosh et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
Rithwik Ramachandran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling
Pascale G. Charest et al.
CELLULAR SIGNALLING (2007)
Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects
Samuel Chackalamannil
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Protease-activated receptor-2 simultaneously directs β-arrestin-1-dependent inhibition and Gαq-dependent activation of phosphatidylinositol 3-kinase
Ping Wang et al.
BIOCHEMISTRY (2006)
Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation
EB Kelso et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes
SR Macfarlane et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target
T Kanke et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Protease-activated receptors: Contribution to physiology and disease
VS Ossovskaya et al.
PHYSIOLOGICAL REVIEWS (2004)
Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-κB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding
Z Darieva et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
A novel Gαq/11-selective inhibitor
J Takasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Potent and metabolically stable agonists for protease-activated receptor-2: Evaluation of activity in multiple assay systems in vitro and in vivo
A Kawabata et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Protease-activated receptor 2 in colon cancer - Trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation
D Darmoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo
S Seeliger et al.
FASEB JOURNAL (2003)
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
M Azzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proteinase-activated receptor-2-induced colonic inflammation in mice: Possible involvement of afferent neurons, nitric oxide, and paracellular permeability
N Cenac et al.
JOURNAL OF IMMUNOLOGY (2003)
Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2
N Cenac et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFκB-dependent transcription and stabilization by serine 15 phosphorylation
SJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
p38 MAPK-mediated activation of NF-κB by the RhoGEF domain of Bcr
M Korus et al.
ONCOGENE (2002)
Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear
J Kawagoe et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory κB kinases in NCTC 2544 keratinocytes
T Kanke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
P2Y receptor-mediated inhibition of tumor necrosis factor α-stimulated stress-activated protein kinase activity in EAhy926 endothelial cells
A Paul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
M Steinhoff et al.
NATURE MEDICINE (2000)
Share Paper
